4//SEC Filing
IMMUNE PHARMACEUTICALS INC 4
Accession 0001144204-15-003557
CIK 0001208261operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:19 PM ET
Size
5.8 KB
Accession
0001144204-15-003557
Insider Transaction Report
Form 4
Berdugo Gad
Director
Transactions
- Award
Stock Option
2015-01-22+370,000→ 370,000 totalExercise: $1.92Exp: 2025-01-22→ Common Stock (370,000 underlying)
Footnotes (2)
- [F1]The stock options shall vest over a three-year period, with 1/3 of the stock options granted vesting annually commencing on January 22, 2016.
- [F2]These securities were issued pursuant to an employment agreement, dated January 21, 2015, entered into between the Issuer and the Reporting Person in connection with the appointment of the Reporting Person as Executive Vice President and Chief Financial Officer of the Issuer, effective January 22, 2015.
Documents
Issuer
IMMUNE PHARMACEUTICALS INC
CIK 0001208261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001208261
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:19 PM ET
- Size
- 5.8 KB